Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21752)

• Formulation Name: Ursodeoxycholic acid 300 mg capsule
• Company: NCS HealthCare of KY, Inc dba Vangard Labs; Stat Rx USA

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ursodeoxycholic acid	(DMCUT21)	Cholelithiasis	DC11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant